Abivax

CEO Marc de Garidel brings prior large‑cap operating and US build‑out experience from Ipsen. The broader team includes an experienced CMO and development leaders with deep IBD credentials. Execution on a complex, multi‑continent Phase 3 program and well‑sequenced financing suggests solid operational discipline.

The governance and leadership quality are positives, though we will ultimately judge by regulatory outcomes, launch execution and capital discipline post‑approval.